CCL2 KD also reduced tumor proliferation by as much as 83%, with an average number of EdU+ cells/mm2 tumor decreased from 458 to 78 per 6 h (Fig. 8l–n, Supplementary Table 3). The gene discussed is CCL2; the disease is neoplasm.